|
WO2021077107A1
|
|
Compositions and methods for delivering a bacterial metabolite to a subject
|
|
WO2021050965A1
|
|
Compositions and methods for treating autism spectrum disorder
|
|
US2020281991A1
|
|
Methods and compositions for treating disorders related to a gut dysbiosis
|
|
US2020197449A1
|
|
Compositions and Methods for Treating Alopecia and Related Disorders
|
|
US2020164000A1
|
|
Compositions and methods for treating disorders related to a gut dysbiosis
|
|
WO2020069280A1
|
|
Compositions and methods for treating epilepsy and related disorders
|
|
US2020016218A1
|
|
Methods and compositions for treating ulcerative colitis
|
|
BR112020017090A2
|
|
MICROBIOMA RELATED IMMUNOTHERAPIES
|
|
US2021121503A1
|
|
Fecal microbiota transplantation for treating ulcerative colitis
|
|
AU2018272048A1
|
|
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
|
|
US2020038455A1
|
|
Compositions and methods for treating diverticulitis and related disorders
|
|
CA3058818A1
|
|
Compositions and methods for treating parkinson's disease (pd) and related disorders
|
|
WO2018071532A1
|
|
Compositions and methods for treating chronic fatigue syndrome and related disorders
|
|
WO2018071534A1
|
|
Compositions and methods for treating irritable bowel syndrome and related disorders
|
|
WO2018071537A1
|
|
Compositions and methods for treating multiple sclerosis and related disorders
|
|
US2020046773A1
|
|
Compositions and Method for Treating Primary Sclerosing Cholangitis and Related Disorders
|
|
US2018099011A1
|
|
Compositions and Methods for Treating Irritable Bowel Syndrome and Related Disorders
|
|
US2018099010A1
|
|
Compositions and methods for treating multiple sclerosis and related disorders
|
|
US2018099013A1
|
|
Compositions and Methods for Treating Chronic Fatigue Syndrome and Related Disorders
|
|
US2018036352A1
|
|
Methods for treating ulcerative colitis
|
